December 13, 2021

Update from COM-COV vaccine study on omicron

Scientists running the COM-COV study have done some preliminary analysis of neutralising antibody titres against the omicron variant, from samples from people who’d either been vaccinated with two doses of the Pfizer-BioNTech or with two doses of the Oxford AstraZeneca COVID-19 vaccine.

Journalists dialled in to this briefing to hear from the scientists who have done the research and to ask any questions.

Please note this data is a preprint, so it is early work that has not yet been through peer-review and is not published in a journal.

Speakers included:

Prof Matthew Snape, Professor in Paediatrics and Vaccinology, University of Oxford, Chief Investigator on COM-COV

Prof Teresa Lambe, Professor & Jenner Investigator, the Jenner Institute, University of Oxford

This Briefing was accompanied by an SMC Roundup of Comments.